Aliases & Classifications for Polyhydramnios

About this section

Aliases & Descriptions for Polyhydramnios:

Name: Polyhydramnios 10 47 12 36 65

Classifications:



External Ids:

Disease Ontology10 DOID:8488
ICD1027 O40
ICD9CM29 657, 657.0
MeSH36 D006831
NCIt42 C92848
UMLS65 C0020224

Summaries for Polyhydramnios

About this section
Wikipedia:68 Polyhydramnios (polyhydramnion, hydramnios, polyhydramnios) is a medical condition describing an excess... more...

MalaCards based summary: Polyhydramnios is related to polyhydramnios, megalencephaly, and symptomatic epilepsy and muscular hypertrophy-hepatomegaly-polyhydramnios syndrome. An important gene associated with Polyhydramnios is STRADA (STE20-Related Kinase Adaptor Alpha), and among its related pathways are LKB1 signaling events and Diuretics Pathway, Pharmacodynamics. Affiliated tissues include placenta, lung and bone, and related mouse phenotypes are vision/eye and renal/urinary system.

Disease Ontology:10 A placenta disease that is characterized by an excess of amniotic fluid in the amniotic sac.

Related Diseases for Polyhydramnios

About this section

Diseases related to Polyhydramnios via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 279)
idRelated DiseaseScoreTop Affiliating Genes
1polyhydramnios, megalencephaly, and symptomatic epilepsy12.6
2muscular hypertrophy-hepatomegaly-polyhydramnios syndrome12.3
3fetal akinesia syndrome x-linked11.3
4long qt syndrome 1310.4KCNJ1, SLC12A1
5laubry-pezzi syndrome10.4KCNJ1, SLC12A1
6perlman syndrome10.4
7lethal congenital contracture syndrome 710.4
8oligodontia-colorectal cancer syndrome10.3STK11, STRADA
9hepatitis10.3
10lethal short limb skeletal dysplasia al gazali type10.3CNTNAP1, ZBTB42
11restrictive dermopathy, lethal10.2
12multiple pterygium syndrome, lethal type10.2
13chondrodysplasia, blomstrand type10.2
14nemaline myopathy 1010.2
15fetal akinesia deformation sequence10.2
16bartter syndrome, type 210.2
17lethal congenital contracture syndrome 610.2
18bartter syndrome, type 110.2
19twin-to-twin transfusion syndrome10.2
20bartter disease10.2
21oligohydramnios10.2
22duodenal atresia10.2
23tracheal agenesis10.2
24cervicitis10.2
25hepatitis c virus10.1
26esophagitis10.1
27hepatitis c10.1
28cerebritis10.1
29pancreatitis10.1
30bartter syndrome, type 310.1CLCNKB, KCNJ1, SLC12A1
31b-cell lymphomas10.1CLCNKB, KCNJ1, SLC12A1
32chromophobe adenocarcinoma10.1CLCNKB, KCNJ1, SLC12A1
33anisomastia10.1CLCNKB, KCNJ1, SLC12A1
34pseudobulbar palsy10.1CLCNKB, KCNJ1, SLC12A1
35orofaciodigital syndrome10.1CLCNKB, KCNJ1, SLC12A1
36lung cancer10.0
37breast cancer10.0
38metachromatic leukodystrophy10.0
39arthritis10.0
40hydrocephalus10.0
41leukemia10.0
42osteoarthritis10.0
43lymphoma10.0
44nasopharyngitis10.0
45leukodystrophy10.0
46rhinoscleroma10.0
47dementia10.0
48prostatitis10.0
49thyroiditis10.0
50neuronitis10.0

Graphical network of the top 20 diseases related to Polyhydramnios:



Diseases related to polyhydramnios

Symptoms for Polyhydramnios

About this section

Drugs & Therapeutics for Polyhydramnios

About this section

Drugs for Polyhydramnios (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 36)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
GlyburideapprovedPhase 410710238-21-83488
Synonyms:
1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea
1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea
1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea
1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea
10238-21-8
5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide
5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide
5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide
AB00051949
AC1L1G1Q
AC1Q44V7
AKOS001487495
Abbenclamide
Adiab
Apo-Glibenclamide
Azuglucon
BIDD:GT0239
BPBio1_000344
BRD-K36927236-001-06-0
BRN 2230085
BSPBio_000312
BSPBio_001351
BSPBio_003053
Bastiverit
Benclamin
Betanase
Betanese 5
Bio-0156
Bio1_000076
Bio1_000565
Bio1_001054
Bio2_000071
Bio2_000551
C07022
C23H28ClN3O5S
CAS-10238-21-8
CBiol_001790
CHEBI:5441
CHEMBL472
CID3488
CPD000058229
Calabren
Cytagon
D00336
D005905
DB01016
Daonil
Debtan
Dia-basan
Diabeta
Diabeta (TN)
Diabiphage
Dibelet
DivK1c_000481
Duraglucon
EINECS 233-570-6
EU-0100499
Euclamin
Euglucan
Euglucon
Euglucon 5
Euglucon N
Euglykon
G 0639
G0639_SIAL
G0639_SIGMA
G2539_SIAL
GBN 5
Gen-Glybe
Gewaglucon
Gilemal
Glamide
Glibadone
Gliban
Gliben
Gliben-Puren N
Glibenbeta
Glibenclamid AL
Glibenclamid Basics
Glibenclamid Fabra
Glibenclamid Genericon
Glibenclamid Heumann
Glibenclamid Riker M
Glibenclamid Riker M.
Glibenclamid-Cophar
Glibenclamid-Ratiopharm
Glibenclamida
Glibenclamida [INN-Spanish]
Glibenclamide
Glibenclamide (JP15/INN)
Glibenclamidum
Glibenclamidum [INN-Latin]
Glibenil
Glibens
Glibesyn
Glibet
Glibetic
Glibil
Gliboral
Glicem
Glidiabet
Glimel
Glimide
Glimidstata
Glisulin
Glitisol
Glubate
Gluben
Gluco-Tablimen
Glucobene
Glucohexal
Glucolon
Glucomid
Glucoremed
Glucoven
Glyben
Glybenclamide
Glybenzcyclamide
Glyburide
Glyburide (USP)
Glyburide (micronized)
Glyburide [USAN]
 
Glycolande
Glycomin
Glynase
Glynase (TN)
HB 419
HB 420
HB-419
HB-420
HB419
HB420
HMS1361D13
HMS1568P14
HMS1791D13
HMS1922L08
HMS1989D13
HMS2089L06
HMS2093P04
HMS501I03
Hemi-Daonil
Hexaglucon
Humedia
I06-0716
IDI1_000481
IDI1_033821
KBio1_000481
KBio2_000071
KBio2_000730
KBio2_002639
KBio2_003298
KBio2_005207
KBio2_005866
KBio3_000141
KBio3_000142
KBio3_002273
KBioGR_000071
KBioGR_001897
KBioSS_000071
KBioSS_000730
LS-159295
Lederglib
Libanil
Lisaglucon
Lopac-G-0639
Lopac0_000499
MLS000069721
MLS001077262
Malix
Maninil
Med-Glionil
Melix
Micronase
Micronase (TN)
Micronized glyburide
Miglucan
MolPort-000-784-850
N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea
N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N -cyclohexylurea
N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea
NCGC00015467-01
NCGC00015467-02
NCGC00015467-06
NCGC00015467-16
NCGC00016689-01
NCGC00023447-02
NCGC00023447-04
NCGC00023447-05
NCGC00023447-06
NCGC00023447-07
NCGC00023447-08
NCGC00023447-09
NCGC00023447-10
NCGC00023447-11
NCGC00023447-12
NINDS_000481
Nadib
Neogluconin
Norglicem 5
Normoglucon
Novo-Glyburide
Oprea1_764617
Orabetic
Pira
Praeciglucon
PresTab
Prestwick0_000316
Prestwick1_000316
Prestwick2_000316
Prestwick3_000316
Prestwick_569
Probes1_000431
Probes2_000378
Prodiabet
Renabetic
S1716_Selleck
SAM002564212
SMR000058229
SPBio_001831
SPBio_002531
SPECTRUM2300229
SR-01000000196-5
STK362992
Semi-Daonil
Semi-Euglucon
Semi-Gliben-Puren N
Semi-daonil
Spectrum2_001816
Spectrum3_001327
Spectrum4_001199
Spectrum5_001631
Spectrum_000250
Sugril
Suraben
Tiabet
Tocris-0911
U 26452
U-26452
UNII-SX6K58TVWC
UPCMLD-DP006
UPCMLD-DP006:001
UR 606
Yuglucon
ZINC00537805
glibenclamide
glyburide
2
MetforminapprovedPhase 41645657-24-9, 1115-70-414219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMBG
DMGG
Diabefagos
Diabetosan
Diabex
Diaformin
Dianben
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Meguan
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin Hydrochloride
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
Obimet
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
3Hypoglycemic AgentsPhase 44503
4
BetamethasoneapprovedPhase 1, Phase 2153378-44-99782
Synonyms:
.beta.-Methasone
.beta.-Methasone alcohol
1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol
16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione
16β-Methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione
24024-03-1
34166_FLUKA
34166_RIEDEL
378-44-9
4-08-00-03501 (Beilstein Handbook Reference)
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-16.beta.-methylprednisolone
9-Fluoro-16beta-methylprednisolone
9-Fluoro-16β-methylprednisolone
9-alpha-Fluoro-16-beta-methylprednisolone
9.alpha.-Fluoro-16.beta.-methylprednisolone
9alpha-Fluoro-16 beta-methyl-prednisolone
9alpha-Fluoro-16beta-methylprednisolone
9α-Fluoro-16β-methylprednisolone
AC1L1EYE
AC1L1TT4
AC1Q5HJZ
AKOS001582690
AR-1A7284
AR-1H5595
B1837
B7005_SIAL
B7005_SIGMA
B9675_SIAL
BIDD:PXR0047
BPBio1_000533
BRD-A35108200-001-04-7
BRD-K39188321-001-03-9
BRN 3176546
BSPBio_000483
Bebate
Becort
Bedifos
Betacorlan
Betacortril
Betadexamethasone
Betafluorene
Betamamallet
Betametasona
Betametasona [INN-Spanish]
Betametasone
Betametasone [DCIT]
Betamethasone
Betamethasone (JP15/USP/INN)
Betamethasone Base
Betamethasone Dipropionate
Betamethasone Valearate
Betamethasone Valerate
Betamethasone [USAN:BAN:INN:JAN]
Betamethasone [USAN:INN:BAN:JAN]
Betamethasone alcohol
Betamethasone cream
Betamethasone dipropionate
Betamethasone sodium phosphate
Betamethasone valerate
Betamethasonum
Betamethasonum [INN-Latin]
Betamethasonvalerat Mikron
Betamethazone
Betapredol
 
Betasolon
Betnelan
Betsolan
C22H29FO5
CHEBI:3077
CHEMBL632
CID3003
CID9782
CPD000339803
Celestene
Celeston
Celestona
Celestone
Celestone Syrup and Tablets
Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone
Cellestoderm
Cidoten
D00244
D1961
DB00443
Desacort-Beta
Diprolene
EINECS 206-825-4
Flubenisolone
HMS1569I05
HSDB 3015
Hormezon
I06-0121
KST-1A3042
LS-118466
LT00441022
Luxiq
Luxiqo
MLS-0310139.0001
MLS000686794
MLS000859943
MLS001066413
MLS001332616
MLS002153244
Methazon
MolPort-003-845-025
MolPort-007-981-051
NCGC00164401-01
NCGC00164401-02
NSC 39470
NSC-39470
NSC39470
Prestwick0_000362
Prestwick1_000362
Prestwick2_000362
Prestwick3_000362
Prestwick_703
Rinderon
Rinderon (TN)
Rinderon A
S1500_Selleck
SAM002589959
SCH 4831
SCH-4831
SMP1_000043
SMR000058601
SMR000339803
SPBio_002404
UNII-9842X06Q6M
Valisone
Visubeta
ZINC03876136
beta-Methasone
beta-Methasone alcohol
betamethasone
5Hormone AntagonistsPhase 1, Phase 210002
6HormonesPhase 1, Phase 211748
7Respiratory System AgentsPhase 1, Phase 23931
8Betamethasone-17,21-dipropionatePhase 1, Phase 2153
9Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 1, Phase 29988
10glucocorticoidsPhase 1, Phase 23896
11Anti-Asthmatic AgentsPhase 1, Phase 22796
12Betamethasone benzoatePhase 1, Phase 2153
13Anti-Inflammatory AgentsPhase 1, Phase 28478
14Betamethasone ValeratePhase 1, Phase 21532152-44-5
15Betamethasone sodium phosphatePhase 1, Phase 2153
16
Insulin, isophaneapproved23053027-39-7
Synonyms:
Humulin N
 
Isophane Insulin
NPH Insulin
Novolin N
17
Zincapproved14777440-66-623994, 32051
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
18
Insulin Detemirapproved189169148-63-45311023
Synonyms:
Insulin detemir
Insulin detemir recombinant
Levemir
 
Levemir flexpen
Levemir innolet
Levemir penfill
NN-304
19
Cholecalciferolapproved, nutraceutical79967-97-06221, 10883523, 5280795
Synonyms:
()-Vitamin D3
(+)-Vitamin D3
(+)-vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol
47763_SUPELCO
57651-82-8
67-97-0
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
9,10-Secocholesta-5,7,10(19)-trien-3-ol
9,10-Secocholesta-5,7,10-trien-3-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
Activated 7-dehydrocholesterol
Arachitol
BPBio1_000460
BSPBio_000418
BSPBio_002408
Bio-0845
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
CID7067440
CID7251172
CID7251174
CID9821465
Calciol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol D3
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferolum
 
Colecalciferol
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Devaron
DivK1c_006276
Duphafral D3 1000
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
Ebivit
FeraCol
Granuvit D3
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC-375571
NSC375571
Oleovitamin D3
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Prestwick_63
Provitamine
Provitina
Quintox
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SR-05000001559
SR-05000001559-3
ST057172
SpecPlus_000180
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
Spectrum_001163
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
VITAMIN D
VITAMIN D3 POWDER
VITAMIN_D3
Vi-De3
Vi-de-3-hydrosol
VidDe-3-hydrosol
Videkhol
Vigantol
Vigorsan
Vitamin D3
Vitamin D3 emulsifiable
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
bmse000507
calciol
cholecalciferol
delta-D
vitamin d-3
20
Ergocalciferolapproved, nutraceutical92350-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
21Isophane Insulin, Human141
22Insulin, Globin Zinc4278
23Isophane insulin, beef141
24Insulin, Long-Acting123
25insulin4278
26Insulin, Short-Acting87
27vitamin d1524
28Vitamins3857
29Pharmaceutical Solutions7004
30Trace Elements3900
31Micronutrients3901
32Calcium, Dietary4678
33Ergocalciferols923
34Bone Density Conservation Agents2600
35Vitamin D2Nutraceutical923
36CalciferolNutraceutical1074

Interventional clinical trials:

(show all 11)
idNameStatusNCT IDPhase
1A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes MellitusEnrolling by invitationNCT01563120Phase 4
2Syringe or Continuous Amnioreduction for Symptomatic Polyhydramnios. A Prospective Randomized Study.CompletedNCT00236340Phase 3
3Tracheal Occlusion To Accelerate Lung Growth (TOTAL) Trial for Severe Pulmonary HypoplasiaRecruitingNCT01240057Phase 2, Phase 3
4Prenatal Steroids for Treatment of Congenital Cystic Adenomatoid Malformations (CCAM)TerminatedNCT00670956Phase 1, Phase 2
5Studying Fetal Breathing PatternsCompletedNCT00066976
6Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in PregnancyCompletedNCT01837680
7Maternal and Perinatal Outcome in Women With History of Premature Labor in Previous PregnancyCompletedNCT01375439
8Vitamin D Treatment and Hypocalcemic Pregnant WomenRecruitingNCT02021864
9Chewing Gums to Stimulate Intestinal Motility After Cesarean SectionRecruitingNCT02386748
10Sonographic Assessment of Fetal Deglutition Associated With Hydramnion:Its Absence is Indicative of Central Nervous System (CNS) PathologyEnrolling by invitationNCT00687752
11The Value of Prenatal Ultrasound in Complicated Twin Pregnancy and Its Correlation With Chromosomal AnomaliesNot yet recruitingNCT02732717

Search NIH Clinical Center for Polyhydramnios


Cochrane evidence based reviews: polyhydramnios

Genetic Tests for Polyhydramnios

About this section

Anatomical Context for Polyhydramnios

About this section

MalaCards organs/tissues related to Polyhydramnios:

33
Placenta, Lung, Bone, Endothelial, Brain, Liver, Testes

Animal Models for Polyhydramnios or affiliated genes

About this section

MGI Mouse Phenotypes related to Polyhydramnios:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053917.7AQP1, AQP3, CNTNAP1, FGFR3, HSD17B4, STK11
2MP:00053677.5AQP1, AQP3, CLCNKB, FGFR3, FH, KCNJ1
3MP:00053897.4AFP, AQP1, CNTNAP1, FGFR3, HSD17B4, SLC12A1
4MP:00053786.9AQP1, AQP3, CNTNAP1, FGFR3, HSD17B4, KCNJ1
5MP:00053866.7AFP, AQP1, AQP3, CNTNAP1, FGFR3, HSD17B4
6MP:00053766.5AFP, AQP1, AQP3, CLCNKB, FGFR3, FH
7MP:00107685.7AFP, AQP1, AQP3, CNTNAP1, FGFR3, FH

Publications for Polyhydramnios

About this section

Articles related to Polyhydramnios:

(show top 50)    (show all 293)
idTitleAuthorsYear
1
Inhibition of NOS-NO System Prevents Autoimmune Orchitis Development in Rats: Relevance of NO Released by Testicular Macrophages in Germ Cell Apoptosis and Testosterone Secretion. (26046347)
2015
2
Update and Mutational Analysis of SLC20A2: A Major Cause of Primary Familial Brain Calcification. (25726928)
2015
3
Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors. (25941351)
2015
4
Anesthesia considerations for cesarean delivery in a patient with Loeys-Dietz syndrome. (25689361)
2015
5
MicroRNA profile in site-specific head and neck squamous cell cancer. (25862914)
2015
6
The comparison of endogenous angiogenesis inhibitors in normotensive and preeclamptic placentas: an immunohistochemical study. (24205998)
2014
7
Oral administration of haloperidol at clinically recommended doses elicits smaller parkinsonian effects but more tardive dyskinesia in rats. (23455196)
2013
8
Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor. (24118374)
2013
9
Membranous glomerulonephritis, psoriasis and etanercept. A chance or causal association? (22421953)
2012
10
Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression. (21601305)
2011
11
Xanthogranulomatous cystitis arising from the posterior wall of the bladder. (22216402)
2011
12
Granzyme A- and B-cluster deficiency delays acute lung injury in pneumovirus-infected mice. (20018616)
2010
13
c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells. (19427836)
2009
14
Human heat shock protein 27 overexpressing mice are protected against hepatic ischemia and reperfusion injury. (19461484)
2009
15
Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. (18801366)
2008
16
The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. (17468196)
2007
17
Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation. (17420690)
2007
18
Electron transfer complex formation between oxygenase and ferredoxin components in Rieske nonheme iron oxygenase system. (17161368)
2006
19
Protocol-based titration of intravenous terbutaline decreases length of stay in pediatric status asthmaticus. (16502398)
2006
20
Seventy-five gram glucose tolerance test to assess carbohydrate malabsorption and small bowel bacterial overgrowth. (16718794)
2006
21
Monozygotic twins with Asperger syndrome: differences in behaviour reflect variations in brain structure and function. (16459007)
2006
22
An N-terminally acetylated Arf-like GTPase is localised to lysosomes and affects their motility. (16537643)
2006
23
Adenoid cystic carcinoma and mucoepidermoid carcinoma of the maxillary sinus: report of a 44-year experience of 25 cases from a single institution. (17052584)
2006
24
Microtubule disruption inhibits autophagosome-lysosome fusion: implications for studying the roles of aggresomes in polyglutamine diseases. (15325591)
2004
25
HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors. (15075535)
2004
26
Methotrexate as a first-line corticosteroid-sparing therapy in a cohort of uveitis and scleritis. (14533032)
2003
27
Temporal gene expression profile of human precursor B leukemia cells induced by adhesion receptor: identification of pathways regulating B-cell survival. (12393420)
2003
28
Avasimibe Pfizer. (12498009)
2002
29
Asperger syndrome: tests of right hemisphere functioning and interhemispheric communication. (12199132)
2002
30
Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations. (10752643)
2000
31
Renal-hepatic-pancreatic dysplasia: a broad entity. (11186898)
2000
32
Vascular permeability factor expression in cerebellar hemangioblastomas: correlation with tumor-associated cysts. (10222417)
1999
33
Confirmation of linkage of Van der Woude syndrome to chromosome 1q32: evidence of association with STR alleles suggests possible unique origin of the disease mutation. (10589394)
1999
34
Short ragweed allergen induces eosinophilic lung disease in HLA-DQ transgenic mice. (10377177)
1999
35
The importance of serum IgE for level and longitudinal change in airways hyperresponsiveness in COPD. (9824387)
1998
36
Genetic typing of human and food isolates of Listeria monocytogenes from episodes of listeriosis. (9556182)
1998
37
Prognostic relevance of immunohistology, tumor size and vascular space involvement in axillary node negative breast cancer. (9651658)
1998
38
Molecular cloning of the cDNA encoding human deoxyribonuclease II. (9446563)
1998
39
Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons. (9305869)
1997
40
Routine rapid Mycobacterium species assignment based on species-specific allelic variation in the 65-kilodalton heat shock protein gene (hsp65). (9278615)
1997
41
Growth factor/cytokine secretion by a permanent human endometrial cell line with embryotrophic properties. (8844310)
1996
42
Correlation between serum immunoglobulin A concentrations and allergic manifestations in infants. (1625088)
1992
43
Griseofulvin-induced aneuploidy and meiotic delay in female mouse germ cells. II. Cytogenetic analysis of one-cell zygotes. (1373824)
1992
44
High mobility group proteins 1 and 2 function as general class II transcription factors. (2119799)
1990
45
Binswanger's disease: a review of the literature and a personal contribution. (2693096)
1989
46
Panfacial cellulitis with contralateral orbital cellulitis and blindness after tooth extraction. (264256)
1977
47
Congenital dyserythropoietic anemia, type II (Hempas). First five reported cases in Italy. (4451733)
1974
48
Fatal myocardial infarction in an 11 year old boy associated with a unique coronary artery anomaly. (6020311)
1967
49
Malignant nephrosclerosis without retinal edema in a child; long-term observations and renal function studies. (14902103)
1952
50

Variations for Polyhydramnios

About this section

Expression for genes affiliated with Polyhydramnios

About this section
Search GEO for disease gene expression data for Polyhydramnios.

Pathways for genes affiliated with Polyhydramnios

About this section

Pathways related to Polyhydramnios according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.9STK11, STRADA
29.6CLCNKB, KCNJ1, SLC12A1

GO Terms for genes affiliated with Polyhydramnios

About this section

Biological processes related to Polyhydramnios according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1renal water homeostasisGO:000309110.1AQP1, AQP3
2glycerol transportGO:001579310.0AQP1, AQP3
3odontogenesisGO:004247610.0AQP1, AQP3
4water transportGO:000683310.0AQP1, AQP3
5potassium ion transportGO:00068139.9AQP1, KCNJ1, SLC12A1
6positive regulation of protein serine/threonine kinase activityGO:00719029.9STK11, STRADA
7transmembrane transportGO:00550859.2AQP1, AQP3, CLCNKB, SLC12A1
8transportGO:00068108.4AFP, AQP1, AQP3, CLCNKB, SLC12A1

Sources for Polyhydramnios

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet